Cholangitis diagnostic criteria: Difference between revisions

	Cholangitis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Cholangitis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Cholangitis diagnostic criteria On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Cholangitis diagnostic criteria All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Cholangitis diagnostic criteria
CDC on Cholangitis diagnostic criteria
Cholangitis diagnostic criteria in the news
Blogs on Cholangitis diagnostic criteria
Directions to Hospitals Treating Cholangitis
Risk calculators and risk factors for Cholangitis diagnostic criteria

VisualWikitext

Latest revision as of 16:01, 15 December 2017

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]

Diagnostic criteria

An algorithm for diagnosis of cholangitis:^[1]^[2]

Diagnosis of
acute cholangitis

Definitive diagnosis

Signs of infection and pus finding in bile during:
•ERCP
•PTCA
•Surgery

Charcot triad
•Fever
•Jaundice
•Abdominal pain

Reynold's pentad (includes 2 extra features)
•Sepsis
•Mental confusion

Tokyo guidelines 2013(TG 13)^‡

A.Systemic inflammation
A-1. Fever and/or shaking chills
A-2. Laboratory data: evidence of inflammatory response

B.Cholestasis
B-1. Jaundice
B-2. Laboratory data: abnormal liver function tests

C.Imaging
C-1. Biliary dilatation
C-2. Evidence of the etiology on imaging (stricture, stone, stent etc.)

Suspected diagnosis: One item in A + one item in either B or C
Definite diagnosis: One item in A, one item in B and one item in C

Note: ERCP= Endoscopic retrograde cholangiopancreatography, PTCA =Percutaneous transhepatic cholangiography

A-2: Abnormal white blood cell counts, increase of serum C-reactive protein levels, and other changes indicating inflammation

B-2: Increased serum ALP, γGTP (GGT), AST and ALT levels.

Thresholds TG-13^‡
Category^‡	Clinical/ Lab feature	Test/Units	Value
A1	Fever	Body temp	>38° C
A2	Evidence of inflammatory response	WBC (x1000μ/L)	<4 or>10
A2	Evidence of inflammatory response	CRP (mg/dl)	≥1
B1	Jaundice	Total bilirubin (mg/dL)	≥ 2
B2	Abnormal liver function test	ALP (IU)	>1.5 x STD
		γGTP (IU)	>1.5 x STD
		AST (IU)	>1.5 x STD
		AST (IU)	>1.5 x STD

STD=upper limit of normal value, ALP= alkaline phosphatase, γGTP (GGT)= γ-glutamyltransferase, AST= aspartate aminotransferase, ALT= alanine aminotransferase

An algorithm showing course of management:

Signs of acute cholangitis

•Hospitalization
•IV fluids
•Broad spectrum antibiotics

Improvement after hospitalization and/or hydration
and/or broad spectrum antibiotics

Yes

No

Mild cholangitis

Organ dysfunction present?
•Hypotension
(which requires dobutamine or dopamine
@ 5μg/kg/min)
•Confusion
•PaO2:FiO2 ratio<300
•Serum creatinine>177 μmol/L

Elective ERCP and stone clearance

No

Yes

Moderate cholangitis

Severe cholangitis

ERCP within 24-48 hours
•Stone clearance if stable
•Stent if unstable

Urgent ERCP and stent

References

↑ Lee, John G. (2009). "Diagnosis and management of acute cholangitis". Nature Reviews Gastroenterology & Hepatology. 6 (9): 533–541. doi:10.1038/nrgastro.2009.126. ISSN 1759-5045.
↑ Kiriyama, Seiki; Takada, Tadahiro; Strasberg, Steven M.; Solomkin, Joseph S.; Mayumi, Toshihiko; Pitt, Henry A.; Gouma, Dirk J.; Garden, O. James; Büchler, Markus W.; Yokoe, Masamichi; Kimura, Yasutoshi; Tsuyuguchi, Toshio; Itoi, Takao; Yoshida, Masahiro; Miura, Fumihiko; Yamashita, Yuichi; Okamoto, Kohji; Gabata, Toshifumi; Hata, Jiro; Higuchi, Ryota; Windsor, John A.; Bornman, Philippus C.; Fan, Sheung-Tat; Singh, Harijt; de Santibanes, Eduardo; Gomi, Harumi; Kusachi, Shinya; Murata, Atsuhiko; Chen, Xiao-Ping; Jagannath, Palepu; Lee, Sung Gyu; Padbury, Robert; Chen, Miin-Fu; Dervenis, Christos; Chan, Angus C.W.; Supe, Avinash N.; Liau, Kui-Hin; Kim, Myung-Hwan; Kim, Sun-Whe (2013). "TG13 guidelines for diagnosis and severity grading of acute cholangitis (with videos)". Journal of Hepato-Biliary-Pancreatic Sciences. 20 (1): 24–34. doi:10.1007/s00534-012-0561-3. ISSN 1868-6974.

[Lee2009-1] Lee, John G. (2009). "Diagnosis and management of acute cholangitis". Nature Reviews Gastroenterology & Hepatology. 6 (9): 533–541. doi:10.1038/nrgastro.2009.126. ISSN 1759-5045.

[KiriyamaTakada2013-2] Kiriyama, Seiki; Takada, Tadahiro; Strasberg, Steven M.; Solomkin, Joseph S.; Mayumi, Toshihiko; Pitt, Henry A.; Gouma, Dirk J.; Garden, O. James; Büchler, Markus W.; Yokoe, Masamichi; Kimura, Yasutoshi; Tsuyuguchi, Toshio; Itoi, Takao; Yoshida, Masahiro; Miura, Fumihiko; Yamashita, Yuichi; Okamoto, Kohji; Gabata, Toshifumi; Hata, Jiro; Higuchi, Ryota; Windsor, John A.; Bornman, Philippus C.; Fan, Sheung-Tat; Singh, Harijt; de Santibanes, Eduardo; Gomi, Harumi; Kusachi, Shinya; Murata, Atsuhiko; Chen, Xiao-Ping; Jagannath, Palepu; Lee, Sung Gyu; Padbury, Robert; Chen, Miin-Fu; Dervenis, Christos; Chan, Angus C.W.; Supe, Avinash N.; Liau, Kui-Hin; Kim, Myung-Hwan; Kim, Sun-Whe (2013). "TG13 guidelines for diagnosis and severity grading of acute cholangitis (with videos)". Journal of Hepato-Biliary-Pancreatic Sciences. 20 (1): 24–34. doi:10.1007/s00534-012-0561-3. ISSN 1868-6974.

[1]

[2]

@@ Line 4: / Line 4: @@
 ==Diagnostic criteria==
+An algorithm  for diagnosis of cholangitis:<ref name="Lee2009">{{cite journal|last1=Lee|first1=John G.|title=Diagnosis and management of acute cholangitis|journal=Nature Reviews Gastroenterology & Hepatology|volume=6|issue=9|year=2009|pages=533–541|issn=1759-5045|doi=10.1038/nrgastro.2009.126}}</ref><ref name="KiriyamaTakada2013">{{cite journal|last1=Kiriyama|first1=Seiki|last2=Takada|first2=Tadahiro|last3=Strasberg|first3=Steven M.|last4=Solomkin|first4=Joseph S.|last5=Mayumi|first5=Toshihiko|last6=Pitt|first6=Henry A.|last7=Gouma|first7=Dirk J.|last8=Garden|first8=O. James|last9=Büchler|first9=Markus W.|last10=Yokoe|first10=Masamichi|last11=Kimura|first11=Yasutoshi|last12=Tsuyuguchi|first12=Toshio|last13=Itoi|first13=Takao|last14=Yoshida|first14=Masahiro|last15=Miura|first15=Fumihiko|last16=Yamashita|first16=Yuichi|last17=Okamoto|first17=Kohji|last18=Gabata|first18=Toshifumi|last19=Hata|first19=Jiro|last20=Higuchi|first20=Ryota|last21=Windsor|first21=John A.|last22=Bornman|first22=Philippus C.|last23=Fan|first23=Sheung-Tat|last24=Singh|first24=Harijt|last25=de Santibanes|first25=Eduardo|last26=Gomi|first26=Harumi|last27=Kusachi|first27=Shinya|last28=Murata|first28=Atsuhiko|last29=Chen|first29=Xiao-Ping|last30=Jagannath|first30=Palepu|last31=Lee|first31=Sung Gyu|last32=Padbury|first32=Robert|last33=Chen|first33=Miin-Fu|last34=Dervenis|first34=Christos|last35=Chan|first35=Angus C.W.|last36=Supe|first36=Avinash N.|last37=Liau|first37=Kui-Hin|last38=Kim|first38=Myung-Hwan|last39=Kim|first39=Sun-Whe|title=TG13 guidelines for diagnosis and severity grading of acute cholangitis (with videos)|journal=Journal of Hepato-Biliary-Pancreatic Sciences|volume=20|issue=1|year=2013|pages=24–34|issn=18686974|doi=10.1007/s00534-012-0561-3}}</ref>
+{{familytree/start}}
+{{familytree | | | | | | | | | |A01| | | | | |A01= '''Diagnosis of <br>acute cholangitis'''}}
+{{familytree | | | | | | | | | | |!| | | | | | | | }}
+{{familytree | | |,|-|-|-|-|-|-|-|+|-|-|-|-|-|-|.| }}
+{{familytree | | |!| | | | | | | |!| | | | | | |!| }}
+{{familytree |boxstyle=text-align: left| |B01| | | | | |B02| | | | |B03|B01='''Definitive diagnosis'''<br><br>Signs of infection and pus finding in bile during:<br>•[[ERCP]]<br>•[[PTCA]]<br>•Surgery|B02='''Charcot triad'''<br>•[[Fever]]<br>•[[Jaundice]]<br>•[[Abdominal pain]]<br><br>'''Reynold's pentad''' (includes 2 extra features)<br>•[[Sepsis]]<br>•[[Mental confusion]]|B03= '''Tokyo guidelines 2013(TG 13)<sup>‡</sup>  '''<br><br>A.'''Systemic inflammation'''<br>A-1. [[Fever]] and/or shaking [[chills]]<br>A-2. Laboratory data: evidence of inflammatory response<br><br>B.'''Cholestasis'''<br>B-1. Jaundice<br>B-2. Laboratory data: abnormal liver function tests<br><br>C.'''Imaging'''<br>C-1. Biliary dilatation<br>C-2. Evidence of the etiology on imaging (stricture, stone, stent etc.)<br><br>Suspected diagnosis: One item in A + one item in either B or C<br>'''Definite diagnosis''': One item in A, one item in B and one item in C}}
+{{familytree/end}}
+ Note: ERCP= [[Endoscopic retrograde cholangiopancreatography]], PTCA =[[Percutaneous transhepatic cholangiography]]<br>
+ A-2: Abnormal white blood cell counts, increase of serum [[C-reactive protein]] levels, and other changes indicating inflammation<br>
+ B-2: Increased serum [[ALP]], γGTP ([[GGT]]), [[AST]] and [[ALT]] levels.
+{| class="wikitable"
+! colspan="4" |Thresholds TG-13<sup>‡</sup>
+|-
+!Category<sup>‡</sup>
+!Clinical/
+Lab feature
+!Test/Units
+!Value
+|-
+|A1
+|Fever
+|Body temp
+|>38° C
+|-
+| rowspan="2" |A2
+| rowspan="2" |Evidence of inflammatory response
+|WBC (x1000μ/L)
+|<4 or>10
+|-
+|CRP (mg/dl)
+|≥1
+|-
+|B1
+|Jaundice
+|Total bilirubin
+(mg/dL)
+|≥ 2
+|-
+| rowspan="4" |B2
+| rowspan="4" |Abnormal liver function test
+|ALP (IU)
+|>1.5 x STD
+|-
+|γGTP (IU)
+|>1.5 x STD
+|-
+|AST (IU)
+|>1.5 x STD
+|-
+|AST (IU)
+|>1.5 x STD
+|}
+ STD=upper limit of normal value, ALP= alkaline phosphatase, γGTP (GGT)= γ-glutamyltransferase, AST= aspartate aminotransferase, ALT= alanine aminotransferase
+*An algorithm showing course of management:
 {{familytree/start}}
-{{familytree | | | | | | | | |A01| | | | | |A01= '''Diagnosis of <br>acute cholangitis'''}}
+{{familytree | | | | | | | | | |A01| | | | | |A01= '''Signs of acute cholangitis'''}}
-{{familytree | | | | | | | | | |!| | | | | | | | }}
+{{familytree | | | | | | | | | | |!| | | | | | | | }}
-{{familytree | | |,|-|-|-|-|-|-|+|-|-|-|-|-|-|.| }}
+{{familytree | | | | | | | | | |B01| | | | | | | |B01=•Hospitalization<br>•IV fluids<br>•Broad spectrum antibiotics }}
-{{familytree | | |!| | | | | | |!| | | | | | |!| }}
+{{familytree | | | | | | | | | | |!| | | | | | | | }}
-{{familytree |boxstyle=text-align: left| |B01| | | | | |B02| | | | |B03|B01='''Definitive diagnosis'''<br>Signs of infection and pus finding in bile during:<br>•ERCP<br>•PTCA<br>•Surgery|B02='''Charcot triad'''<br>•Fever<br>•Jaundice<br>•Abdominal pain<br>'''Reynold's pentad''' (includes 2 extra features)<br>•Sepsis<br>•Mental confusion|B03= '''Tokyo guidelines 2013(TG 13)'''<br>A.'''Systemic inflammation'''<br>A-1. Fever and/or shaking chills<br>A-2. Laboratory data: evidence of inflammatory response<br>B.'''Cholestasis'''<br>B-1. Jaundice<br>B-2. Laboratory data: abnormal liver function tests<br>C.'''Imaging'''<br>C-1. Biliary dilatation<br>C-2. Evidence of the etiology on imaging (stricture, stone, stent etc.)<br>Suspected diagnosis: One item in A + one item in either B or C<br>'''Definite diagnosis''': One item in A, one item in B and one item in C}}
+{{familytree | | | | | | | | | |C01| | | | | | | |C01=Improvement after hospitalization and/or hydration<br> and/or broad spectrum antibiotics}}
+{{familytree | | | | | | | | | | |!| | | | | | | | }}
+{{familytree | | | | | |,|-|-|-|-|^|-|-|-|-|.| | | }}
+{{familytree | | | | | |!| | | | | | | | | |!| | | }}
+{{familytree | | | | | D01 | | | | | | | | D02 | | |D01=Yes|D02=No}}
+{{familytree | | | | | |!| | | | | | | | | |!| | | }}
+{{familytree |boxstyle=text-align: left | | | | | E01 | | | | | | | | E02 | E01=Mild cholangitis| E02='''Organ dysfunction present?''' <br> •[[Hypotension]] <br>(which requires [[dobutamine]] or [[dopamine]]<br> @ 5μg/kg/min)<br> •[[Confusion]] <br> •PaO2:FiO2 ratio<300<br>•Serum [[creatinine]]>177 μmol/L}}
+{{familytree | | | | | |!| | | | | | | | | |!| | | }}
+{{familytree | | | | | F01 | | | | | | | | |!| |F01=Elective [[ERCP]] and stone clearance}}
+{{familytree | | | | | | | | | | | | | | | |!| | | }}
+{{familytree | | | | | | | | | |,|-|-|-|-|-|^|-|.}}
+{{familytree | | | | | | | | |G01| | | | | | G02 |G01= No|G02=Yes| }}
+{{familytree | | | | | | | | | |!| | | | | | | |!| | }}
+{{familytree | | | | | | | | |H01| | | | | |H02| H01=Moderate cholangitis|H02=Severe cholangitis }}
+{{familytree | | | | | | | | | |!| | | | | | | |!| | }}
+{{familytree |boxstyle=text-align: left | | | | | | | | |I01| | | | | |I02|I01=[[ERCP]] within 24-48 hours<br>•Stone clearance if stable<br>•Stent if unstable|I02= Urgent [[ERCP]] and stent }}
 {{familytree/end}}
-NoteA-2: Abnormal white blood cell counts, increase of serum C-reactive protein levels, and other changes indicating inflammation<br>
-B-2: Increased serum ALP, cGTP (GGT), AST and ALT levels.
 ==References==
 {{reflist|2}}

Cholangitis diagnostic criteria: Difference between revisions

Latest revision as of 16:01, 15 December 2017

Diagnostic criteria

References

Navigation menu